Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 33 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2022Autonomic Afferent Dysregulation in Atrial FibrillationMalik, V.; Elliott, A.D.; Thomas, G.; Mishima, R.S.; Pitman, B.; Middeldorp, M.E.; Fitzgerald, J.L.; Young, G.D.; Roberts-Thomson, K.C.; Arnolda, L.F.; Lau, D.H.; Sanders, P.
2022Sex-Related Differences in Atrial Remodeling in Patients With Atrial Fibrillation: Relationship to Ablation OutcomesWong, G.R.; Nalliah, C.J.; Lee, G.; Voskoboinik, A.; Chieng, D.; Prabhu, S.; Parameswaran, R.; Sugumar, H.; Al-Kaisey, A.; McLellan, A.; Ling, L.-H.; Sanders, P.; Kistler, P.M.; Kalman, J.M.
2013Aortic stiffness in lone atrial fibrillation: A novel risk factor for arrhythmia recurrenceLau, D.; Middeldorp, M.; Brooks, A.; Ganesan, A.; Roberts-Thomson, K.; Stiles, M.; Leong, D.; Abed, H.; Lim, H.; Wong, C.; Willoughby, S.; Young, G.; Kalman, J.; Abhayaratna, W.; Sanders, P.; Calvert, J.
2013Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation a randomized clinical trialAbed, H.; Wittert, G.; Leong, D.; Shirazi, M.; Bahrami, B.; Middeldorp, M.; Lorimer, M.; Lau, D.; Antic, N.; Brooks, A.; Abhayaratna, W.; Kalman, J.; Sanders, P.
2010Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleLopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
2011Effect of dietary fish oil on atrial fibrillation after cardiac surgeryFarquharson, A.; Metcalf, R.; Sanders, P.; Stuklis, R.; Edwards, J.; Gibson, R.; Cleland, L.; Sullivan, T.; James, M.; Young, G.
2012Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillationDimitri, H.; Ng, M.; Brooks, A.; Kuklik, P.; Stiles, M.; Lau, D.; Antic, N.; Thornton, A.; Saint, D.; McEvoy, R.; Antic, R.; Kalman, J.; Sanders, P.
2009Prognostic impact of types of atrial fibrillation in acute coronary syndromesLau, D.; Huynh, L.; Chew, D.; Astley, C.; Soman, A.; Sanders, P.
2012Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialLopes, R.; Al-Khatib, S.; Wallentin, L.; Yang, H.; Ansell, J.; Bahit, M.; De Caterina, R.; Dorian, P.; Easton, J.; Erol, C.; Ezekowitz, J.; Gersh, B.; Granger, C.; Hohnloser, S.; Horowitz, J.; Hylek, E.; McMurray, J.; Mohan, P.; Vinereanu, D.; Alexander, J.
2011Apixaban versus Warfarin in patients with atrial fibrillationGranger, C.; Alexander, J.; McMurray, J.; Lopes, R.; Hylek, E.; Hanna, M.; Al-Khalidi, H.; Ansell, J.; Avezum, A.; Atar, D.; Bahit, M.; Diaz, R.; Easton, J.; Ezekowitz, J.; Garcia, D.; Geraldes, M.; Gersh, B.; Golitsyn, S.; Goto, S.; Hermosillo, A.; et al.